Insufficient Evidence on Safety & Effectiveness to achieve FDA Approval for MiItraclip

Published date : 19 March 2013
Article date : 19 March 2013


Nasdaq reports that the FDA has recommended against approving Abbott Vascular's Mitraclip heart device on the basis that they believe there is insufficient evidence to demonstrate that it is safe and effective.

The device is designed to repair heart valves in patients who are not considered to be good candidates for valve-replacement surgery. 

The article says that on Monday, the FDA released a review of Mitraclip in advance of a meeting this Wednesday where an advisory committee will consider the manufacturer's application for approval. Apparently, the review recommends that the device should remain available as an investigational device so it can be used in two ongoing clinical trials where the patients are considered high-risk and inoperable.

Source: Jennifer Corbett Dooren, Dow Jones Business News, 18 March 2013.

Read the full article here.

See our details about the Mitraclip

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.